Robert L. Panek - Concepedia

Author

Robert L. Panek

Also Known As

Maeder, André, Panek, Robert, R L Panek, R PANEK, R Panek, R. L. PANEK, R. L. Panek, R. Panek, R.L. Panek, ROBERT L. PANEK

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Warde Medical Laboratory Pfizer (United States)Michigan Medicine Cancer Society of New Zealand University of Auckland

About

Robert L. Panek is an author at Warde Medical Laboratory specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	816
2	Biochemistry	5	5	435
3	Natural Sciences	4	4	344
4	Health Sciences	2	2	118
5	Cell Biology	2	2	35

Robert L. Panek

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Subclasses of angiotensin II binding sites and their functional significance. David T. Dudley, Robert L. Panek, Terry C. Major, Molecular Pharmacology	1990	378
Inhibition of Sphingomyelin Synthesis Reduces Atherogenesis in Apolipoprotein E–Knockout Mice Tae‐Sik Park, Robert L. Panek, Sandra Bak Mueller, Circulation	2004	220
Structure−Activity Relationships for a Novel Series of Pyrido[2,3-<i>d</i>]pyrimidine Tyrosine Kinase Inhibitors James M. Hamby, Cleo J. C. Connolly, Mel C. Schroeder, Journal of Medicinal Chemistry PharmacotherapyCompound LibraryHeterocycle ChemistryChemical BiologyPharmaceutical Chemistry	1997	141
2-Substituted Aminopyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones. Structure−Activity Relationships Against Selected Tyrosine Kinases and in Vitro and in Vivo Anticancer Activity S. KLUTCHKO, James M. Hamby, Diane H. Boschelli, Journal of Medicinal Chemistry	1998	130
A Contrasting effect of the diabetic state upon the contractile responses of aortic preparations from the rat and rabbit Richard Head, Penelope A. Longhurst, Robert L. Panek, British Journal of Pharmacology	1987	115
Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice Tae Woo Park, Wendy S. Rosebury, Erick Kindt, Pharmacological Research InflammationVascular DiseaseCardiovascular DiseaseAtherosclerotic PlaquesMedicine	2008	113
In Vitro Pharmacological Characterization of PD 166285, a New Nanomolar Potent and Broadly Active Protein Tyrosine Kinase Inhibitor Robert L. Panek, Gina H. Lu, S. KLUTCHKO, Journal of Pharmacology and Experimental Therapeutics	1997	94
Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice Tae‐Sik Park, Robert L. Panek, Mark D. Rekhter, Atherosclerosis InflammationOxysterolBiochemistryMedicineLipid Peroxidation	2006	91
In Vitro Biological Characterization and Antiangiogenic Effects of PD 166866, a Selective Inhibitor of the FGF-1 Receptor Tyrosine Kinase Robert L. Panek, Gina H. Lu, Tawny K. Dahring, Journal of Pharmacology and Experimental Therapeutics	1998	88
Design of a functional hexapeptide antagonist of endothelin Wayne L. Cody, Annette M. Doherty, John X. He, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryTranslational PharmacologyNeuropeptidesEndothelinwayne L. Cody	1992	84

Page 1